Skip to content

Safinamide in Parkinson’s disease: No hint of added benefit

  • by

From the Institute for Quality and Efficiency in Health Care media release: Safinamide (trade name: Xadago) has been available since February 2015 as add-on therapy for the treatment of mid- to late-stage Parkinson disease in adults.… 

Diabetes complications linked to rising risk of dementia

From the The Endocrine Society media release: People who have diabetes and experience high rates of complications are more likely to develop dementia as they age than people who have fewer diabetic complications, according to…